HRT Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

HRT Financial’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-112,460	Closed	-$8.46M	–	3851
2022 Q2	$8.46M	Buy	+112,460	New	+$5M	0.09%	163
2021 Q2	–	Sell	-6,869	Closed	-$649K	–	3775
2021 Q1	$649K	Buy	+6,869	New	+$817K	0.01%	1577

HRT Financial's TPTX Position: Q3 2022 in Review

HRT Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 112,460 shares — an estimated $8.46M sold.

HRT Financial first reported a position in TPTX in Q1 2021 and held it in 2 quarters. The position peaked at $8.46M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

HRT Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
HRT Financial sold 112,460 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $8.46M.
HRT Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
HRT Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $8.46M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.